Huaren Pharmaceutical (300110.SZ) and its subsidiaries are being sued for a dispute over equity transfer, involving an amount of 2.84 billion yuan.

Huaren Pharmaceutical (300110.SZ) announced that due to a dispute over equity transfer, the company and its wholly-owned subsidiaries Xi'an Qujiang Huaren Pharmaceutical Co., Ltd. ("Qujiang Huaren") and Anhui Hengxing Pharmaceutical Co., Ltd. ("Anhui Hengxing") recently received a "Summons" and a "Civil Complaint" from the Xi'an Intermediate People's Court, involving a total amount of 284 million RMB.